Versican

Versican

Versican is a large extracellular matrix proteoglycan that plays a crucial role in cell adhesion, proliferation, migration, and tissue morphogenesis. It is a member of the lectican family of proteoglycans and is characterized by its ability to bind hyaluronan and other extracellular matrix components.

Structure

Versican is composed of a core protein to which glycosaminoglycan (GAG) chains are attached. The core protein consists of several domains, including an N-terminal globular domain, a central GAG attachment region, and a C-terminal globular domain. The GAG chains are primarily chondroitin sulfate, which contribute to the proteoglycan's high negative charge and ability to interact with other matrix molecules.

Isoforms

Versican exists in several isoforms, which are generated through alternative splicing of its mRNA. The main isoforms are V0, V1, V2, and V3, each differing in the length and composition of their GAG attachment regions. These isoforms have distinct biological functions and tissue distributions.

Function

Versican plays a significant role in the extracellular matrix by influencing cell behavior and tissue structure. It is involved in:

• Cell Adhesion and Migration: Versican modulates cell adhesion and migration by interacting with cell surface receptors and other matrix components.
• Cell Proliferation: It can influence cell proliferation by affecting growth factor signaling pathways.
• Tissue Morphogenesis: Versican is crucial during embryonic development and tissue repair processes.

Role in Disease

Versican is implicated in various pathological conditions, including:

• Cancer: Altered expression of versican is associated with tumor progression and metastasis in several cancers.
• Cardiovascular Disease: Versican accumulation in the vascular wall is linked to atherosclerosis and restenosis.
• Inflammatory Diseases: It plays a role in inflammation by modulating leukocyte adhesion and migration.

Clinical Significance

Due to its involvement in numerous physiological and pathological processes, versican is a potential biomarker and therapeutic target. Research is ongoing to develop strategies to modulate versican expression and function in disease contexts.

See Also

• Proteoglycan
• Extracellular matrix
• Chondroitin sulfate
• Hyaluronan

External Links

• [Versican at Wikidata](https://www.wikidata.org/wiki/Q210000)